NO930822L - 1,4-dioksino(2,3,-6)pyridinderivater - Google Patents

1,4-dioksino(2,3,-6)pyridinderivater

Info

Publication number
NO930822L
NO930822L NO93930822A NO930822A NO930822L NO 930822 L NO930822 L NO 930822L NO 93930822 A NO93930822 A NO 93930822A NO 930822 A NO930822 A NO 930822A NO 930822 L NO930822 L NO 930822L
Authority
NO
Norway
Prior art keywords
dioxino
pyridine
Prior art date
Application number
NO93930822A
Other languages
English (en)
Other versions
NO930822D0 (no
Inventor
Gerald Guillaumet
Pascal Poirot
Abdelhakim Benarab
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NO930822D0 publication Critical patent/NO930822D0/no
Publication of NO930822L publication Critical patent/NO930822L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/056Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
NO93930822A 1992-03-06 1993-03-05 1,4-dioksino(2,3,-6)pyridinderivater NO930822L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400603 1992-03-06

Publications (2)

Publication Number Publication Date
NO930822D0 NO930822D0 (no) 1993-03-05
NO930822L true NO930822L (no) 1993-09-07

Family

ID=8211623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930822A NO930822L (no) 1992-03-06 1993-03-05 1,4-dioksino(2,3,-6)pyridinderivater

Country Status (9)

Country Link
EP (1) EP0559285A1 (no)
JP (1) JPH069641A (no)
KR (1) KR930019679A (no)
AU (1) AU3395293A (no)
CA (1) CA2090767A1 (no)
FI (1) FI930964A7 (no)
MX (1) MX9301235A (no)
NO (1) NO930822L (no)
ZA (1) ZA931343B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06100139B2 (ja) * 1988-02-08 1994-12-12 トヨタ自動車株式会社 内燃機関の燃料供給量補正装置
JP3430540B2 (ja) * 1993-02-26 2003-07-28 いすゞ自動車株式会社 オゾン脱臭システム
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
FR2727682A1 (fr) * 1994-12-02 1996-06-07 Pf Medicament Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament
TW446706B (en) * 1995-02-07 2001-07-21 Janssen Pharmaceutica Nv Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines, a pharmaceutical composition containing them, their intermediates and a process for their preparation
JO2352B1 (en) 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
US6656950B2 (en) * 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
CN100352820C (zh) * 2002-09-12 2007-12-05 惠氏公司 抗抑郁的杂环稠合的苯并二噁烷的氮杂环甲基衍生物
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
EP2007377A4 (en) 2006-04-06 2011-08-17 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
JP6546654B2 (ja) 2014-08-22 2019-07-17 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 淋菌感染を治療するための三環式含窒素化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA855563B (en) * 1984-07-30 1986-05-28 Merrell Dow Pharma Glutarimide antianxiety and antihypertensive agents
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DE3726425A1 (de) * 1987-03-18 1988-09-29 Bayer Ag Basisch substituierte saccharine
US4910302A (en) * 1988-12-19 1990-03-20 American Home Products Corporation Psychotropic polycyclic imides

Also Published As

Publication number Publication date
ZA931343B (en) 1993-09-24
FI930964L (fi) 1993-09-07
FI930964A0 (fi) 1993-03-04
KR930019679A (ko) 1993-10-18
EP0559285A1 (en) 1993-09-08
MX9301235A (es) 1993-09-01
NO930822D0 (no) 1993-03-05
JPH069641A (ja) 1994-01-18
FI930964A7 (fi) 1993-09-07
AU3395293A (en) 1993-09-09
CA2090767A1 (en) 1993-09-07

Similar Documents

Publication Publication Date Title
NO920018L (no) 1,3-oksatiolannukleosidanaloger
FI935260A7 (fi) Telekommunikationssystem, i vilket debiteringsdatan registreras i handtelefonen
FI931763L (fi) 4,1-bensoxazepinderivat och deras anvaendning
AT397656B (de) (6,7-substituierte-8-alkoxy-1-cyclopropyl-1,4-
KR900700567A (ko) 2,3-디플루오로비페닐
FI933151L (fi) 5,10 metylentetrahydrofolsyre-cyklodextrin-inneslutningsfoereningar
DE69502542D1 (de) 2-Phenyl-7-chlor-perhydroimidazo(1,5-a)pyridine
FI930296L (fi) 1,4-disubstituerade piperaziner
NO930822L (no) 1,4-dioksino(2,3,-6)pyridinderivater
FI894629A7 (fi) Uusia 3,4-diaminokinoliini- ja -pyridiiniyhdisteitä
FI932516A7 (fi) Styrkonsol, i synnerhet foer motorfordon
DE59010722D1 (de) 2,4-Dimethyl-6-s-alkylphenole
NO932842D0 (no) 1,4-benzodioksanderivater
FI931747A0 (fi) Reflexkropp, isynnerhet foer vaegmarkeringar
FI931459L (fi) Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
FI932874L (fi) 6,7-modifierade 11b-aryl-4-estrener
FI934928A7 (fi) Foerfarande foer framstaellning av 3,7-dialkylxantiner fraon 3-alkylxantiner
FI933605A0 (fi) Sammansaettningar av 1-klor-2,2,2-trifluoretyldifluormetyleter och partiellt fluorerade alkanoler
FI932396A7 (fi) Foerfarande foer framstaellning av en dubbelskyddad 2,3-hydroximetylcyklobutanol
FI891186A0 (fi) Foerfarande foer bestaemning av koefficienter i en transversal ekvalisator.
FI934895L (fi) Antiarrytmiska, arylfusionerade och hetarylfusionerade 2,4-diazepin- och 2,4-diazocin foereningar
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
NO933592D0 (no) Alkoksymetylsubstituerte pyridinbifenyler
FI930237L (fi) Foerfarande foer framstaellning av 4,6-dialkoxipyrimidiner